These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29107586)

  • 21. Cytotoxicity evaluation and DNA interaction of Ru
    de Almeida PSVB; de Arruda HJ; Sousa GLS; Ribeiro FV; de Azevedo-França JA; Ferreira LA; Guedes GP; Silva H; Kummerle AE; Neves AP
    Dalton Trans; 2021 Oct; 50(41):14908-14919. PubMed ID: 34609400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the potential of ruthenium(II)-phosphine-mercapto complexes as new anticancer agents.
    Palmeira-Mello MV; Costa AR; de Oliveira LP; Blacque O; Gasser G; Batista AA
    Dalton Trans; 2024 Jul; 53(26):10947-10960. PubMed ID: 38895770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
    Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
    J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
    Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS
    Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
    Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
    Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.
    Mallepally RR; Putta VR; Chintakuntla N; Vuradi RK; Kotha LR; Sirasani S
    J Fluoresc; 2016 May; 26(3):1101-13. PubMed ID: 27067208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes.
    de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of heterobimetallic topoisomerase I and II inhibitor complexes: in vitro DNA binding, interaction with 5'-GMP and 5'-TMP and cleavage studies.
    Arjmand F; Muddassir M
    J Photochem Photobiol B; 2010 Oct; 101(1):37-46. PubMed ID: 20638859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed ligand complexes of Cu(II)/Zn(II) ions containing (m-)/(p-) carboxylato phenyl azo pentane 2,4-dione and 2,2'-bipyridine/1,10 phenanthroline: Synthesis, characterization, DNA binding, nuclease and topoisomerase I inhibitory activity.
    Hasan MA; Kumari N; Singh K; Singh K; Mishra L
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():208-17. PubMed ID: 26210016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Zn(II) complexes with non-steroidal anti-inflammatory ligand, flufenamic acid: Characterization, topoisomerase I inhibition activity, DNA and HSA binding studies.
    Smolková R; Zeleňák V; Smolko L; Sabolová D; Kuchár J; Gyepes R
    J Inorg Biochem; 2017 Dec; 177():143-158. PubMed ID: 28963956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
    de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
    Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonyl-heterobimetallic Ru(II)/Fe(II)-complexes containing polypyridyl ligands: Synthesis, characterization, cellular viability assays and interactions with biomolecules.
    Dávila-Rodríguez MJ; Barolli JP; de Oliveira KM; Colina-Vegas L; da Silva Miranda F; Castellano EE; Von Poelhsitz G; Batista AA
    Arch Biochem Biophys; 2018 Dec; 660():156-167. PubMed ID: 30389443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
    Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
    J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
    Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
    J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Half sandwich Ru(ii)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line.
    Colina-Vegas L; Luna-Dulcey L; Plutín AM; Castellano EE; Cominetti MR; Batista AA
    Dalton Trans; 2017 Oct; 46(38):12865-12875. PubMed ID: 28920989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.
    Lenis-Rojas OA; Fernandes AR; Roma-Rodrigues C; Baptista PV; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Dalton Trans; 2016 Dec; 45(47):19127-19140. PubMed ID: 27868117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.